Suppr超能文献

趋化素与癌症。

Chemerin and Cancer.

机构信息

Department of Obstetrics and Gynecology, University Medical Center Regensburg, 93053 Regensburg, Germany.

Department of Internal Medicine I, University Medical Center Regensburg, 93053 Regensburg, Germany.

出版信息

Int J Mol Sci. 2019 Jul 31;20(15):3750. doi: 10.3390/ijms20153750.

Abstract

Chemerin is a multifunctional adipokine with established roles in inflammation, adipogenesis and glucose homeostasis. Increasing evidence suggest an important function of chemerin in cancer. Chemerin's main cellular receptors, chemokine-like receptor 1 (CMKLR1), G-protein coupled receptor 1 (GPR1) and C-C chemokine receptor-like 2 (CCRL2) are expressed in most normal and tumor tissues. Chemerin's role in cancer is considered controversial, since it is able to exert both anti-tumoral and tumor-promoting effects, which are mediated by different mechanisms like recruiting innate immune defenses or activation of endothelial angiogenesis. For this review article, original research articles on the role of chemerin and its receptors in cancer were considered, which are listed in the PubMed database. Additionally, we included meta-analyses of publicly accessible DNA microarray data to elucidate the association of expression of chemerin and its receptors in tumor tissues with patients' survival.

摘要

趋化素是一种多功能脂肪因子,其在炎症、脂肪生成和葡萄糖稳态中具有既定作用。越来越多的证据表明趋化素在癌症中具有重要功能。趋化素的主要细胞受体,趋化因子样受体 1(CMKLR1)、G 蛋白偶联受体 1(GPR1)和 C-C 趋化因子受体样 2(CCRL2)在大多数正常和肿瘤组织中表达。趋化素在癌症中的作用被认为存在争议,因为它能够发挥抗肿瘤和促进肿瘤的作用,这些作用是通过不同的机制介导的,如招募先天免疫防御或激活内皮血管生成。在这篇综述文章中,考虑了趋化素及其受体在癌症中的作用的原始研究文章,这些文章列在 PubMed 数据库中。此外,我们还包括了公开可用的 DNA 微阵列数据的荟萃分析,以阐明肿瘤组织中趋化素及其受体的表达与患者生存的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600d/6695761/4f0fa7a1979a/ijms-20-03750-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验